Literature DB >> 11484834

Age-related incidence of spontaneous non-neoplastic lesions in a colony of Han:AURA hamsters.

K Kamino1, T Tillmann, E Boschmann, U Mohr.   

Abstract

In toxicologic testing or experimental studies using animals, an adequate knowledge of spontaneously occurring lesions is required. 144 male and 184 female untreated Syrian golden hamsters (strain Han:AURA) were kept for life under standard laboratory conditions and an investigation of non-neoplastic lesions in relationship to the lifespan was performed. The average lifespan of the males was 106 weeks and that of the female hamsters 97 weeks. While cartilage degeneration of the sternum and fatty degeneration of the femoral bone marrow occurred already in the first half of life with high incidence, the majority of lesions were observed in the second half. The most frequent non-neoplastic changes in various organs were fatty change, calcification, cystic change, hyperplasia and amyloidosis. Such spontaneous lesions were discussed in connection with the same alterations which can also be induced by chemical or hormonal agents.

Entities:  

Mesh:

Year:  2001        PMID: 11484834     DOI: 10.1078/0940-2993-00164

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  2 in total

1.  Delta-sarcoglycan gene therapy halts progression of cardiac dysfunction, improves respiratory failure, and prolongs life in myopathic hamsters.

Authors:  Masahiko Hoshijima; Takeharu Hayashi; Young E Jeon; Zhenxing Fu; Yusu Gu; Nancy D Dalton; Mark H Ellisman; Xiao Xiao; Frank L Powell; John Ross
Journal:  Circ Heart Fail       Date:  2010-10-29       Impact factor: 8.790

2.  Proceedings of the 2013 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Michael C Boyle; Molly H Boyle; Michelle C Cora; Torrie A Crabbs; Connie A Cummings; Margarita M Gruebbel; Crystal L Johnson; David E Malarkey; Elizabeth F McInnes; Thomas Nolte; Cynthia C Shackelford; Jerrold M Ward
Journal:  Toxicol Pathol       Date:  2013-12-13       Impact factor: 1.902

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.